Please login to the form below

Not currently logged in
Email:
Password:

Chiesi targets patient adherence via mobile app

Initiative will see asthma and COPD patients receive device training support

ChiesiChiesi Limited, the UK affiliate of Italian healthcare company Chiesi Farmaceutici, has launched a new mobile app for adult patients with asthma or chronic obstructive pulmonary disease (COPD) to support with patient adherence and device technique.

The app, which will be used by healthcare professionals, is specifically catered to those who have been prescribed Chiesi’s Fostair (beclometasone/formoterol) pressurised metered-dose inhaler (pMDI) or dry powder inhaler Fostair NEXThaler.

According to the group, inefficient inhalation technique is a common problem as patients tend to forget to how to use their inhalers appropriately and introducing new errors with time.

Inhaler misuse has been associated with increased risk of hospitalisation, courses of oral steroids and poor disease control.

Patients using Chiesi’s app will be able to review their inhaler technique and can share this during their consultations with their HCPs.

The new app also offers dose reminders and a dose history review to help recognise patterns.

Tom Delahoyde, managing director of Chiesi LTD, said: “Our aim is to help HCPs to better support patients in achieving the desired outcome from their Fostair treatment.

“With this in mind, we have designed an app which aims to support HCPs with patients inhaler technique training.”

The app is available on both Android and Apple operating systems.

Article by
Gemma Jones

18th June 2018

From: Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics